U.S. Interactive Media and Services Stock News

Earlier this month, SentinelOne Inc. expanded its AI-native cybersecurity platform by opening Purple AI Agentic Investigation to customers, launching Singularity Credits for AI-powered workloads, and announcing an upcoming integration of its Prompt Security offering with Amazon Bedrock AgentCore on AWS. Together, these moves deepen SentinelOne’s role in securing enterprise AI agents and workflows, tying autonomous threat investigation directly into a major cloud ecosystem while unifying how...

Alan Greenspan’s death at 100 has pushed Federal Reserve history and monetary policy back into the spotlight, and that matters for some of the biggest financial stocks on your watchlist. When markets recheck old assumptions about interest rates, transparency and central bank credibility, large US banks, asset managers and insurers can see sentiment move quickly. This article looks at how that news connects to today’s US financial heavyweights and what it might mean for investors weighing...

Morgan Stanley’s upgrade of CDW (CDW) to Overweight, tied to resilient enterprise server demand and accelerated AI infrastructure spending, has refocused attention on the stock and its recently announced US$1 billion share buyback. See our latest analysis for CDW. The 1 day share price return of 5.25% following Morgan Stanley’s upgrade comes after a 30 day share price return of 17.36%. Over the same period, the 1 year total shareholder return is down 26.28%, suggesting short term momentum has...

Knowles (KN) is in focus after the company expanded its range of high performance capacitors for pulse power applications, while also committing more resources to testing, process control, and live demonstrations at upcoming industry conferences. See our latest analysis for Knowles. Despite a sharp 6.33% decline in the 1 day share price return to US$40.09, Knowles still carries strong momentum, with a 30 day share price return of 9.36% and a 1 year total shareholder return of 127.91%. This...

Energy headlines are suddenly front and center again, with progress in US Iran talks, loosened export restrictions and a direct communication channel in the Strait of Hormuz all pointing to the possibility of more stable oil flows and extra supply pressure on crude prices. For airlines and transportation stocks that live with fuel as a major cost line, that combination can matter just as much as passenger demand. This article looks at how those developments and the current technical weakness...

Earlier this month, Lineage’s Board of Directors declared a second-quarter 2026 cash dividend of US$0.5325 per share, payable on July 21 to shareholders of record as of June 30, even as the company managed an extended fire at its Boyle Heights cold storage warehouse that triggered emergency responses across Los Angeles. The prolonged warehouse fire, reportedly sparked by rooftop solar work and reaching an ammonia line, has raised questions about Lineage’s safety practices and community...

Lyft (LYFT) is back in focus after Rothschild & Co Redburn shifted its view on the stock, pointing to ride growth pressures as temporary and highlighting expectations around the company’s international expansion plans. See our latest analysis for Lyft. At a share price of $13.82, Lyft has seen its 1 day share price return slip 2.81% and its 7 day share price return ease 3.22%. A 90 day share price return of 4.22% contrasts with a weaker year to date share price return, and the 3 year total...

Charter Communications’ removal from the NASDAQ-100 Index, announced on 19 June 2026, follows its earlier move to let Spectrum customers purchase Netflix directly through The Spectrum App Store. This combination of index exclusion and deeper integration of third-party streaming apps highlights how Charter’s capital markets profile and product ecosystem are evolving in different directions. We’ll now examine how Charter’s NASDAQ-100 exit could influence its broadband-focused investment...

Regeneron Pharmaceuticals (REGN) has drawn investor attention after recent trading that leaves the stock down about 3% over the past month and roughly 18% over the past 3 months, despite positive trailing 1 year returns. See our latest analysis for Regeneron Pharmaceuticals. Against this backdrop, Regeneron Pharmaceuticals shows fading near term momentum, with the share price down about 20% year to date, yet a 1 year total shareholder return of roughly 19% still points to a stronger longer...

In recent days, Monarch Casino & Resort has drawn increased attention as analysts highlighted strong technical momentum signals and reiterated favorable rankings for the stock, underpinned by multiple buy indications and positive earnings estimate revisions. Alongside this rising analyst enthusiasm, the company’s Atlantis Casino Resort Spa brand campaign has added to its profile by earning national creative and video awards, reinforcing the appeal of its Northern Nevada hospitality...

CACI International Inc. recently appointed Dr. Dave Young, age 45, as Executive Vice President and Chief Operating Officer, adding him to the executive leadership team reporting directly to the CEO after senior roles at Lockheed Martin, CAES, and Northrop Grumman. Young’s prior responsibility for a roughly US$7.00 billion national security space business and thousands of staff could meaningfully influence how CACI runs its operations and executes on complex defense and intelligence...

Political spending around AI regulation is exploding, and that is turning compliance, security, and governance into real business for some companies. As lawmakers weigh tighter rules and Big Tech steps up lobbying, investors are starting to look at stocks that could benefit from higher regulatory focus rather than be squeezed by it. This article breaks down how that New York primary fight on AI rules ties back to your portfolio and highlights 3 stocks from an AI Regulation Beneficiaries...

Immunome, Inc. recently dosed the first patient in a Phase 1, first-in-human trial of IM-1617, a potential first-in-class antibody-drug conjugate for advanced solid tumors, incorporating its proprietary TOP1 inhibitor payload HC74. The trial advances Immunome’s antibody-drug conjugate platform by targeting an undisclosed receptor tyrosine kinase linked to tumor survival and immune cell exclusion, with additional IND filings for IM-1340 and IM-1335 planned for mid- and late 2026. We will now...

Hexcel (HXL) has drawn fresh attention after Deutsche Aircraft signed a long-term partnership for composite materials on the D328eco regional turboprop, which ties the stock story more closely to Europe’s sustainable aviation ambitions. See our latest analysis for Hexcel. Despite a recent pullback, with a 1-day share price return down 3.07% and a 7-day share price return down 2.31%, Hexcel’s 30-day and year-to-date share price returns of 11.52% and 25.03%, plus a 1-year total shareholder...

On June 18, 2026, BJ's Wholesale Club Holdings, Inc. reported the results of its annual general meeting, where shareholders rejected a proposal to adopt a majority voting standard, while separate shareholder resolutions on deforestation and GHG emissions reporting were withdrawn. The combination of withdrawn environmental proposals and the failed majority voting measure highlights ongoing tension between shareholder governance priorities and the company’s current oversight framework. We’ll...

GDS Holdings Limited recently filed a shelf registration for up to US$1.01 billion, covering 30,718,359 Class A ordinary shares tied to its employee stock ownership plan (ESOP). This large ESOP-related shelf suggests GDS may lean more on equity-based incentives and potential future share issuance, which could matter for investors assessing dilution and capital-raising choices. Now we’ll examine how this sizable ESOP-linked shelf registration might influence GDS Holdings’ existing investment...

In June 2026, Safety Insurance Group, Inc. amended its revolving credit agreement with Citizens Bank, N.A., doubling the committed facility from US$50,000,000 to US$100,000,000 and extending its maturity to June 9, 2031, while leaving other key terms largely unchanged and keeping the additional capacity undrawn. This move materially expands the company’s liquidity toolkit, signaling an emphasis on maintaining ample, secured borrowing capacity against accounts receivable and related assets...

Ventas (VTR) has drawn attention after appointing Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research, and CEO of Lillibridge Healthcare Services, effective August 2026, following the retirement of Peter J. Bulgarelli. See our latest analysis for Ventas. The executive changes around Ventas come as the stock trades at $85.37, with a 1-day share price return of 2.81% and year to date share price return of 10.40%. The 1-year total shareholder return of 38.46% and 3-year...

In June 2026, Wells Fargo & Company issued multiple fixed-rate, senior unsecured callable notes maturing between 2029 and 2041, alongside recently completed fixed‑income offerings totaling about US$12.84 million in principal, while also being named a preferred home mortgage lender for 3D‑printed homebuilder ICON. The combination of fresh medium‑ and long‑term funding, plus the ICON partnership that extends mortgage access to innovative low‑cost housing, highlights Wells Fargo’s focus on...

Mineralys Therapeutics recently presented post hoc proteomic data from its Phase 3 Launch-HTN and Phase 2b Advance-HTN trials at ENDO 2026, showing lorundrostat’s impact on renin-angiotensin-aldosterone system biomarkers and several heart failure risk markers after 12 weeks of treatment. The finding that lorundrostat reduced multiple candidate causal heart failure biomarkers, including NT-proBNP, adds mechanistic support for exploring heart failure and other cardiorenal indications beyond...

Rising tariffs, geopolitical friction, and tighter cross border financing are pushing global supply chains to rethink where and how goods are produced. That shift is putting a fresh spotlight on reshoring and domestic manufacturing stocks, which could face very different outcomes compared with companies still heavily tied to long, fragile trade routes. This article explains how the latest trade headlines and policy uncertainty connect to that theme, and highlights 3 stocks from our Reshoring...

Robotics and automation are moving from science fiction to the factory floor just as many economies face weak services activity, mixed manufacturing signals, stubborn cost pressures and aging workforces. With PMIs hovering near contraction in key regions and inflation trends still uneven, many companies are looking to physical AI and automation to protect margins, secure supply chains and support growth without relying solely on hiring. This Robotics and Automation Stocks screener focuses on...

Sandisk (NasdaqGS:SNDK) has been hit by a sharp selloff in global tech and memory chip stocks, reversing a year of strong momentum. The pullback followed a market-wide decline led by South Korean chip stocks, with US-listed chip companies moving lower in tandem. The drop comes after a long stretch of optimism around AI-related demand and supply tightness in memory. Investors are reacting to profit-taking, concerns about debt-funded AI spending, and questions about how much future growth is...

DocuSign, Inc. recently launched a new Slackbot app powered by its Iris AI engine, connecting Slack to its Intelligent Agreement Management platform via Model Context Protocol to bring agreement intelligence, workflow automation, and natural language actions directly into Slack conversations. The integration’s ability to pull context from chat history, shared files, organizational hierarchy, and Salesforce data positions DocuSign more deeply within everyday enterprise workflows, potentially...